A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DIH / drug-induced hepatotoxicity

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DIH  (>> Co-occurring Abbreviation)
Long Form:   drug-induced hepatotoxicity
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Evaluation of 3D re-cellularized tissue engineering: a drug-induced hepatotoxicity model for hepatoprotectant research. ALR, DIC, DMEs, TRO
2019 Unimolecular Chemo-fluoro-luminescent Reporter for Crosstalk-Free Duplex Imaging of Hepatotoxicity. CASP3, CFR
2017 Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs. ARV, ATD, CI, ERN1, GWAS, lincRNAs, OR, SNPs, TB
2017 Mechanisms of Drug-Induced Hepatotoxicity. ---
2016 Abdominal Tuberculosis. MDR
2016 Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity. NAT2
2016 Successful desensitization therapy involving fluoroquinolone for the treatment of a solitary tuberculoma: A case report and literature review. DLST, EB, LVFX, PZA, RFP
2015 Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels. EMB, PZA, RMP, TB
2015 Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population. ATDH, CIs, IL-10, IL-4, OR, SNP, TNF-alpha
10  2014 Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis. anti-TB, HBV, HCV, TLI
11  2014 Association of genetic variants with anti-tuberculosis drug induced hepatotoxicity: a high resolution melting analysis. DMEs, HRM, NRs, SNPs, TB, TPs
12  2014 Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity. RMP, SD, TB
13  2014 Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity. PCR-RFLP, TB
14  2014 Hepatotoxicity of anti-tuberculosis chemotherapy in patients with liver cirrhosis. EMB, PZA, RMP, TB
15  2014 The Effect of Garcin in Preventing AntiTB-Induced Hepatitis in Newly Diagnosed Tuberculosis Patients. ---
16  2014 The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients. CYP2E1, CYP3A4, NAT2, PCR, RFLP, TB
17  2013 Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population. anti-TB, GST
18  2013 Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India. CYP2E1, NAT2, SA, TB
19  2012 A fatal case of nafcillin-induced hepatotoxicity: a case report and the literature review. ---
20  2011 Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis. ATT, CYP2E1, NAT2
21  2011 Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity. TB
22  2010 Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. ALP, anti-TB, AST, BMI, MAC, TB
23  2010 Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. ---
24  2009 Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity. anti-TB, AST, AVH
25  2008 Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients. TB
26  2007 Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy. HCV, TB